Barley Barley Crop Icon Brassicas Brassicas Crop Icon Sugar Beet Sugar Beet Carrots Carrots Icon Leeks Leek Icon Maize Maize Icon Oilseed Oilseed Icon Onions Onions Icon Other Cereals Other Cereals Icon O R T Peas And Beans Peas and beans Icon Potatoes Potatoes Icon Salad Crops Salad Crops Icon Soft Fruits Crops Soft Fruits Icon Top Fruits Crops Top Fruits Icon Wheat Crops Wheat Icon Calendar Calendar icon Arrow Next Arrow Previous Close Checkmark

Spring benefits from Liberator application (press release)

Cambridge, 16, January, 2012 –

 

Liberator (diflufenican + flufenacet), the market leading residual herbicide from Bayer CropScience, has now gained full label approval permitting it’s application up to before 31st March, allowing growers a much wider application window.

 

Flufenacet is widely acknowledged as the most robust pre-emergence active substance for control of black-grass, so the new approval increases the flexibility of timing and sequences available to growers.  The changes do not apply to the other major flufenacet product, BASF’s Crystal (flufenacet + pendimethalin).

 

“Under the latest approval a sequential application of an extra 0.3L/ha of Liberator can be applied until before 31st March, to give a maximum seasonal dose of 0.9L/ha, the maximum individual dose remains at 0.6L/ha” says Tim Holt, Bayer CropScience product manager.  “Agronomists and growers have been eagerly awaiting these changes so that Liberator can be used on late-drilled crops which haven’t received a herbicide application going into the new year, following potatoes or sugar beet, for example, or, where growers want to take advantage of the robust residual activity on late germinating black-grass.

 

Keith Norman, technical director at Velcourt agrees, “The extension will be a great help, particularly this year with the autumn being so dry; it will enable growers to top up residuals. Some held back pre-em applications as they waited for black-grass to emerge and this gives them another chance.”

 

“Across our 28,000 hectares of wheat we directly manage or advise on through the Velcourt Agronomy Service, about 30% has challenging black-grass.  Liberator has become the mainstay of our herbicide programme and this latest approval gives greater flexibility particularly where crops are late drilled.”

 

“The increased maximum total dose means Liberator can be used twice in a season  once at the pre-em timing and again as a residual partner with Atlantis WG (mesosulfuron + iodosulfuron),” explains Mr Holt.

 

“There are some restrictions with this new approval, for those considering a sequential application of 0.3L/ha Liberator, the first application of Liberator must have been applied before GS 13 of the crop and at least 6 weeks elapsed between applications. 

 

Another Bayer flufenacet-containing product, Firebird, also has approval for two applications at 0.3L/ha up to 31st March.

 

Contact:

Diana Rees, Tel. no: 01223 2266217

E-Mail: diana.rees@bayer.com

 

Whisper PR, Natalie Reed, Tel no: 01608 637805

E-Mail: natalie.reed@whisper.pr

 

Find more information at www.bayercropscience.co.uk.

 

About Bayer CropScience

Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience, a subgroup of Bayer AG with annual sales of EUR 6.830 billion (2010), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 20,700 and is represented in more than 120 countries. This and further news is available at: www.press.bayercropscience.com.

 

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.